MYTIDE THERAPEUTICS, INC.
Automated platform for rapid, high-purity custom peptide synthesis using solid-phase slug flow coupling and machine learning optimization
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2017
- Latest Form D
- $1.2M, Jan 2023
- Total capital
- $8M
- Federal grants
- $270K
- 1 award · 2020
- Rank in peer group#5 of 17
- Private capital raised
- $7.7M
- 2 Form D · last Jan 2023
- 46 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 5 pending · first 2024
- Rank in peer group#3 of 17
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1.2M
- Private capital raisedForm D · SEC · 1st filing$6.6M
- Federal grantNSF · Phase I · SBIR Phase I: Solid Phase Slug Flow (SPSF) for Drug Discovery$270K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
25months
from MYTIDE THERAPEUTICS, INC.’s first federal award to its first private round.
- First federal award · Jan 2020
- NSF · $270K
- First Form D · Jan 2022
- $6.6M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 17 peers
Line = medianBiotech · System
- Federal grants#5 · top 29%
- Granted patents#3 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Dale ThomasResearcherExecutive Officer, Director, PromoterLinked by $270K in grants as PI
- Errik AndersonDirectorNamed in SEC Form D filings
- Jason NorrisExecutive Officer, Director, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 6- GrantedGripping DeviceUSPTOUS D1,035,730
- PendingA Manufacturing Process for Peptide and Protein ProductionUSPTOApplication 17618781
- PendingMachine Learning-Based Online Optimization Of Solid Phase Slug Flow Peptide SynthesisUSPTOApplication 17535210
Show all 6 patent records
- Gripping DeviceJul 16, 2024 · US D1,035,730Granted
- A Manufacturing Process for Peptide and Protein ProductionAug 18, 2022 · Application 17618781Pending
- Machine Learning-Based Online Optimization Of Solid Phase Slug Flow Peptide SynthesisApr 14, 2022 · Application 17535210Pending
- A Manufacturing Process For Peptide And Protein ProductionApplication PCTUS2020037441Pending
- Manufacturing Process For Peptide And Protein ProductionApplication 63009563Pending
- Slug Flow Process For Peptide And Protein SynthesisApplication 62861821Pending
Related companies, and why
- mytide therapeutics IncShares a founder: Dale Thomas
- Sustained Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Blue Marlin Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- NormunitySimilar federal contract value in Biotech · null in contracts
- Amicus Inc. / DESimilar federal contract value in Biotech · null in contracts
- Scudo Biosciences IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .